A detailed history of Roxbury Financial LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Roxbury Financial LLC holds 1,890 shares of ABT stock, worth $245,756. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,890
Previous 1,886 0.21%
Holding current value
$245,756
Previous $253 Million 6.26%
% of portfolio
0.21%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 05, 2026

BUY
$123.62 - $134.59 $494 - $538
4 Added 0.21%
1,890 $237 Million
Q3 2025

Oct 01, 2025

BUY
$120.51 - $136.62 $361 - $409
3 Added 0.16%
1,886 $253 Million
Q2 2025

Jul 07, 2025

BUY
$123.95 - $138.08 $867 - $966
7 Added 0.37%
1,883 $256 Million
Q1 2025

Apr 09, 2025

SELL
$111.1 - $140.22 $1,333 - $1,682
-12 Reduced 0.64%
1,876 $259 Million
Q4 2024

Jan 30, 2025

BUY
$111.93 - $119.39 $211,323 - $225,408
1,888 New
1,888 $224 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Roxbury Financial LLC Portfolio

Follow Roxbury Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roxbury Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roxbury Financial LLC with notifications on news.